EXTENDED DEADLINE
FOR ABSTRACTS AND CLINICAL CASES:
FEBRUARY 12th, 2023 (23:59 CET)!
Clinical cases and abstracts are eligible to be selected
for an oral or a poster presentation.
About the Conference:
ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management.
They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.
CONFERENCE MAIN SCIENTIFIC TOPICS:
• How I treat smoldering myeloma
• How I treat newly diagnosed multiple myeloma
• From risk stratification to risk-based therapy?
• Should we use MRD testing to determine therapy in multiple myeloma?
• Is there a future role of autologous stem cell transplantation?
• How I treat relapsed multiple myeloma
• The FDA/EMEA and Foundations perspective on multiple myeloma
• Should every patient receive daratumumab in first line?
• You can’t be immune for immune therapy anymore
• Other plasma cell dyscrasias
• The future of multiple myeloma
The programme will include:
Plenary Sessions - Interactive Case Presentations
Roundtables - Panel Discussions -Debates
Poster Walks - Meet the Expert Sessions - Voting technology
With the support of*:
Major Conference Partners
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.